Johnson & Johnson announced today that it received FDA de novo authorization for its Ottava surgical robot system.

In Wednesday's order, U.S. Magistrate Judge Rukhsanah Singh, in the District of New Jersey, raised "deep skepticism" about ...

Nearly six years after unveiling its Ottava robotics platform, Johnson & Johnson (NYSE:JNJ) has finally cleared a major ...

Johnson & Johnson JNJ on Wednesday reported second-quarter 2026 results that topped Wall Street estimates and raised its full ...

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Today, Johnson & Johnson (NYSE: JNJ) (the “Company”), healthcare’s leading, most comprehensive innovation powerhouse, announced manufacturing, research and ...

JNJ is pruning its portfolio while Abbott just dropped $21 billion to expand into cancer diagnostics, and the two strategies ...

For 2026, Johnson & Johnson anticipates operational sales growth in the range of 5.7% to 6.7% with a midpoint of $100 billion or 6.2%. Reported sales growth is expected between 6.2% to 7.2% with a ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Johnson & Johnson is adding to its oncology pipeline with a $3.05 billion deal to acquire Halda Therapeutics, a startup whose first-in-class approach to prostate cancer could overcome drug resistance ...

Johnson & Johnson remains a buy as business momentum accelerates, with Q4 revenue up 9.1% YoY and strong U.S. sales resilience. Their deal with the Trump Administration eliminates tariffs in exchange ...

If health care industry corruption and criminality were a city skyline, it would be booming, with tower cranes and half-built skyscrapers in every direction. Among the downtown giants at the center ...

When most people experience an itch, they think nothing of it; a simple scratch can usually tame it. The itch experienced by people living with atopic dermatitis (AD), commonly known as eczema, is ...